Updates on cardiovascular outcome trials in diabetes

In 2008 the Food and Drug Administration introduced a guidance for industry that requires the investigation of cardiovascular outcomes of glucose-lowering medications. Since then, an increasing number of cardi...

Source: Cardiovascular Diabetology - October 11, 2017 Category: Cardiology Authors: Oliver Schnell, Lars Ryd én, Eberhard Standl and Antonio Ceriello Tags: Review Source Type: research